IDO1 is an immune regulatory gene that was shown to recruit and activate myeloid-derived suppressor cells through a Treg-dependent mechanism that contributed to aggressive tumor growth and poor response to T-cell targeted therapy [69]. This evidence concerns the gene IDO1 and neoplasm.